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Abstract
Background: Patients suffering from ulcerative colitis (UC) bear an increased risk for colorectal cancer. Due to the sparsity of
colitis-associated cancer (CAC) and the long duration between UC initiation and overt carcinoma, elucidating mechanisms
of inflammation-associated carcinogenesis in the gut is particularly challenging. Adequate murine models are thus highly
desirable. For human CACs a high frequency of chromosomal instability (CIN) reflected by aneuploidy could be shown,
exceeding that of sporadic carcinomas. The aim of this study was to analyze mouse models of CAC with regard to CIN.
Additionally, protein expression of p53, beta-catenin and Ki67 was measured to further characterize murine tumor
development in comparison to UC-associated carcinogenesis in men.
Methods: The AOM/DSS model (n = 23) and IL-102/2 mice (n = 8) were applied to monitor malignancy development via
endoscopy and to analyze premalignant and malignant stages of CACs. CIN was assessed using DNA-image cytometry.
Protein expression of p53, beta-catenin and Ki67 was evaluated by immunohistochemistry. The degree of inflammation was
analyzed by histology and paralleled to local interferon-c release.
Results: CIN was detected in 81.25% of all murine CACs induced by AOM/DSS, while all carcinomas that arose in IL-102/2
mice were chromosomally stable. Beta-catenin expression was strongly membranous in IL-102/2 mice, while 87.50% of
AOM/DSS-induced tumors showed cytoplasmatic and/or nuclear translocation of beta-catenin. p53 expression was high in
both models and Ki67 staining revealed higher proliferation of IL-102/2-induced CACs.
Conclusions: AOM/DSS-colitis, but not IL-102/2mice, could provide a powerful murine model to mechanistically investigate
CIN in colitis-associated carcinogenesis.
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Introduction
Patients suffering from ulcerative colitis (UC) face an increased
lifetime risk of developing colorectal cancer (CRC) [1]. Such
inflammation-associated malignancies of the colorectum show
distinct differences to sporadic carcinomas: they develop in younger
patients, more often in males, and synchronous carcinomas are more
frequently found [2]. On the genomic level, it has been hypothesized
that chronic inflammation leads to increased chromosomal instability
(CIN) by reactive oxygen and nitrogen species (RONS), hypermethy-
lation of pericentromeric DNA regions, telomere attrition, and other
less well defined mechanisms [3,4,5]. CIN is observed in chronic
inflammatory conditions such as Barrett’s esophagus, chronic
hepatitis, and UC to a high extent [6,7,8]. In UC, aneuploidy as
the measurable sequela of CIN can be applied as a predictive marker
for malignant transformation and is detectable up to a decade prior to
diagnosis of carcinoma [8,9]. Recently, it could be shown that CIN
characterizes colitis-associated carcinomas (CACs) with a frequency
reaching 100% in a set of 31 CACs analyzed, while contrarily only
75% of sporadic CRCs were found aneuploid [10,11]. Taken
together, mounting evidence suggests a causal relationship between
inflammation and CIN, with presence of CIN being a predictive
marker for both, malignancy development and inferior prognosis
once malignant transformation has occurred.
Elucidating causes and effects of CIN on a mechanistic level
could therefore substantially aid the development of strategies to
prevent and treat cancer with novel, targeted approaches. Thus,
suitable animal models are highly desirable to accelerate research
progress. Preferably, such models should show characteristics
similar to their human counterparts, which in case of colitis-
associated carcinogenesis indispensably comprise aneuploidy.
In addition to CIN, previous studies have demonstrated further
differences between sporadic and colitis-associated carcinogenesis
with regard to canonical pathways of malignant transformation:
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It has long been known that p53-point mutations occur early in
UC-associated neoplastic progression and correlate directly with
aneuploidy [12,13,14,15].
In CRC and other tumors, activation of Wnt-signaling promotes
cell survival and inhibits cell death. Subsequent to activation of the
Wnt-signaling pathway, accumulation and translocation of beta-
catenin from the cell membrane to the cytoplasm and nucleus can
be observed, resulting in activation of a variety of target genes [16].
Only limited data exist on beta-catenin-expression in CAC. One
study focusing on genetic alterations adjacent to the beta-catenin
locus on chromosome 3p22-p21.3 could not find a difference
between the frequency of loss of heterozygosity among UC-
associated and sporadic carcinomas [17]. Contrarily, a recent study
on Wnt-signaling activation in CAC concluded that the pathway is
activated in an early phase of malignant transformation in colitis,
and found nuclear beta-catenin staining helpful in detecting
neoplasia in CAC [18].
A diversity of animal models of UC is commonly used. In one
canonical model colitis is induced with dextran sulphate sodium
(DSS) [19]. Interestingly, long term DSS administration alone can
cause malignant transformation in rodents [20,21], while this
effect is aggravated by additional application of azoxymethane
(AOM), a mutagenic agent that by itself causes the development of
colorectal tumors in mice [22]. Tumors induced with AOM alone
do not show CIN [23]. A dose-dependent promoting effect of DSS
for AOM-induced tumors has been reported, while CIN has not
been studied in the AOM/DSS-model [24].
A complementary murine model of UC is the interleukin 102/2
(IL-102/2)-mouse [25]. In this model, inflammatory changes
commence in the distal colon at about three weeks of age and
progress proximally without additional administration of external
pathogens [26]. Colonic lesions are characterized by inflammatory
infiltrates in the mucosa and submucosa as well as crypt abscesses
[26]. It has been described that at six months of age, 60% of IL-
102/2-mice develop adenocarcinomas [26]. We have previously
shown that lumen filling tumors arise in IL-102/2 mice, which
closely resemble human adenocarcinomas histologically [27].
Furthermore, it has been reported that neoplastic transformation
in these mice can be aggravated by administration of celecoxib
[25,27].
The aim of this project was to characterize murine inflamma-
tion-associated CRCs with regard to CIN and other known
characteristics of their human counterpart. The extent of CIN in
premalignant and malignant stages of two mouse models for
colitis-mediated carcinogenesis was assessed. Furthermore, the
protein expression of p53 and beta-catenin was evaluated in
murine tumors, as well as in an exemplary set of human CACs.
Ki67 staining served to determine the growth fraction of the
tumors. Finally, inflammatory activity was confirmed via endos-
copy, histology, as well as a local increase of the pro-inflammatory
cytokine interferon-c (IFNc)
Materials and Methods
Ethical Considerations
Animal protocols were approved by the regional animal study
committee of Berlin (LAGeSo, approval ID G0297/03) for both
models used in this study.
Mice
All animals were purchased from Harlan Winkelmann
(Borchen, Germany). Altogether, 23 mice treated with AOM
and DSS as described below were used for this study.
Complementarily, eight IL-102/2 mice were investigated.
AOM/DSS-induced tumor development
DSS and AOM were administered to C57BL/6J mice at six
weeks of age as described previously [27]. Briefly, mice received a
single intraperitoneal injection of the mutagenic agent AOM
(12.5 mg/kg body weight). Starting at day five after the AOM
application, 3.5% DSS was dissolved in the drinking water for
three cycles of five days each with intermittent 14-day intervals of
regular drinking water, thereby inducing a chronic DSS colitis.
Endoscopic surveillance was performed as described below on a
weekly basis and mice were sacrificed on day 50, at that point
exhibiting either adenocarcinomas or colitis without overt
neoplasms (see results, table 1).
In total, ten healthy, untreated C57BL/6J-mice were used as
normal controls (figure 1).
IL-102/2-mice
At twelve weeks of age, the cyclooxygenase 2 inhibitor celecoxib
(500 mg/mouse/day) was administered orally to IL-102/2 mice
(C57BL/6J –background, n = 8) for five days as described
previously [25]. Mice were observed for an additional four weeks
and underwent weekly lower endoscopy, before being sacrificed
with or without signs of malignant growth (table 1).
Endoscopic surveillance and post-mortem examination
Tumor development was monitored macroscopically using a
high resolution mouse endoscope system (Karl Storz GmbH,
Tuttlingen, Germany) as described previously [28]. Endoscopies
were performed weekly starting one week after AOM-treatment
and celecoxib-treatment, respectively. Based on observed tumor
development, days 50 and 28 after beginning of each treatment
were chosen as endpoint for the AOM/DSS and IL-102/2 group,
respectively. Endoscopic procedures surveyed on a color monitor
were recorded digitally (DSR-20MD, Sony, Cologne, Germany).
In addition to preparation of colonic tissue as described below,
post-mortem autopsy was performed macroscopically. Particular-
ly, to screen for distant metastases, fresh lung and liver tissue was
cut into 5 mm sections, which were investigated for macroscopical
signs of neoplasms.
DNA-image cytometry
Nuclear DNA ploidy assessments were performed by means of
DNA-image cytometry using Feulgen-stained histological sections
of 8 mm thickness. Staining procedures, cell selection criteria, and
internal standardization were based on methods described previ-
ously [29]. An average number of 110 enterocyte nuclei (range 100
to 120, SD =3.4) were measured per specimen after interactive
selection using a digital imaging system (Ahrens ACAS, Hamburg,
Germany). All DNA values were expressed in relation to internal
staining controls (lymphocytes), which were given the value 2c.
DNA profiles were classified according to Auer [29]. Histograms
characterized by a single peak in the diploid or near-diploid region
(1.5 c–2.5 c) were classified as type I. Type II histograms showed a
single peak in the tetraploid region (3.5 c–4.5 c) or peaks in both the
diploid and tetraploid regions (.90% of the total cell population).
The number of cells with DNA values between the diploid and
tetraploid region and those exceeding the tetraploid region (.4.5 c)
was ,10%. Type III histograms represented highly proliferating
near-diploid cell populations and were comprised of DNA values
ranging between the diploid and the tetraploid region. Only a small
number of cells (,5%) showed more than 4.5 c. The DNA
histograms of types I, II and III thus characterize euploid cell
populations. Type IV histograms showed increased (.5%) and/or
distinctly scattered DNA values exceeding the tetraploid region
Aneuploidy in Murine Colitis-Associated Cancer
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(.4.5 c). These histograms were suggested to reflect aneuploid
populations of enterocyte nuclei.
Colon organ culture and cytokine measurements
Murine colons were cut open longitudinally and washed in PBS.
Strips of 1 cm2 were placed in 48 flat-bottom well culture plates
containing 0.5 ml of serum-free RPMI 1640 with penicillin
(100 U/ml) and streptomycin (100 mg/ml), and were incubated
at 37uC for 24 h. Culture supernatants were harvested, assayed for
IFNc, and total protein content was quantified using the Bio-Rad
protein assay (Bio-Rad Laboratories, Munich, Germany). Murine
IFNc was determined by specific ELISA according to the
manufacturer’s protocols (BD Biosciences, Heidelberg, Germany)
with a quantification range from 20 pg/ml to 10 ng/ml.
Histopathology and Immunohistochemistry
All tumors and mucosa specimens were subjected to Hematoxylin
& Eosin (H&E) staining for histopathology assessment by an
experienced pathologist (H.-A. L). From AOM/DSS-treated mice
or IL-102/2 mice, complete colons were fixed. Paraffin sections
were stained with H&E. Histological signs of inflammation were
evaluated as a combined score of inflammatory cell infiltration (0–
3) and tissue damage (0–3), resulting in a score ranging from 0 to 6
as described previously [30]. Tumor size was scored as follows: 0,
no adenoma; 1, focal; 2, expanded and/or confluent; 3, expanded
and raised; and 4, lumen filling. Antibodies for p53, beta-catenin,
and Ki67 were purchased from DAKO (Hamburg, Germany;
anti-Ki67 antibody; clone TEC3; rat IgG2a), New England
Biolabs (Frankfurt, Germany; anti-beta-catenin antibody; clone
6B3, rabbit IgG), and Cell Signaling (Danvers, MA, USA; anti-
p53 antibody, Ser15; polyclonal rabbit). Staining procedures were
performed according to the manufacturers’ protocols. At least ten
high power fields were used to semiquantitatively assess protein
expression. For immunohistochemistry scoring please refer to
table 1.
Statistical Analyzes
Statistical data analyzes were performed using Microsoft
Excel 2003, DigDB v7.1.3.3 (Sunnyvale, CA, USA), and
XLStat Pro v7.5 (Addinsoft, New York, NY, USA). Data are
expressed in means (using standard error of means, SEM). For
inductive inference, nonparameteric rank-sum tests were used
to compare location parameters of data distributions. Two
independent samples, e.g. of different ploidy status, were
compared using Wilcoxon’s test. Corresponding frequencies
were analyzed by means of Fisher’s exact test. The type 1 error
rate was set to 5%.
Results
Administration of AOM/DSS and IL-10 deficiency result in
colitis-mediated carcinomas
In total, 16 out of 23 mice treated with AOM and DSS
developed colorectal neoplasms after an average age of seven
weeks post AOM administration. Tumor development could be
followed endoscopically and tumors closely resembled human
adenocarcinomas histologically. In mice that developed neoplasms
(n= 16), tumor number ranged from two to 19 per animal with a
median of nine tumors per mouse (figure 1a). From each
individual, one representative tumor was chosen for further
analyses on the basis of tumor size. However, in only one out of
16 cases, invasion through the colonic wall was observed, while all
other carcinomas were characterized by obstructing intraluminar
growth without infiltration beyond the lamina propria mucosae.
Neoplasms were seen exclusively in the colon.
In IL-102/2 mice, at an average age of 15 weeks upcoming
dysplasias progressed to infiltrating adenocarcinomas in a total of
four animals (out of eight animals observed as described in
‘‘methods’’). Tumor number ranged from seven to 24 tumors per
animal, with a median of 16 neoplasms per mouse. One tumor
of each animal was chosen for downstream analyses as
described above. Neoplastic transformation was constrained to
the colorectum.
Macroscopic distant metastases were seen neither after AOM/
DSS-treatment nor in IL-102/2 mice.
Table 1. Ploidy assessment according to Auer’s classification,
p53-, beta-catenin-, and Ki67-immunohistochemistry for
murine tissue analyzed.
No. Auer Aneuploid p53 b-catenin Ki67 / %
AOM-CA1 4 1 2 4 30
AOM-CA2 4 1 1 4 20
AOM-CA3 4 1 1 4 25
AOM-CA4 4 1 2 1 10
AOM-CA5 4 1 1 4 30
AOM-CA6 4 1 1 4 25
AOM-CA7 4 1 1 1 10
AOM-CA8 4 1 1 2 10
AOM-CA9 4 1 2 3 20
AOM-CA10 4 1 2 2 35
AOM-CA11 4 1 3 2 10
AOM-CA12 3 0 3 3 15
AOM-CA13 3 0 1 4 20
AOM-CA14 4 1 1 5 5
AOM-CA15 3 0 2 4 40
AOM-CA16 4 1 3 4 40
IL10-CA1 3 0 3 1 40
IL10-CA2 3 0 3 1 40
IL10-CA3 3 0 3 1 35
IL10-CA4 3 0 3 1 40
AOM-CNTRL1 3 0 1 2 20
AOM-CNTRL2 1 0 0 1 5
AOM-CNTRL3 1 0 1 1 5
AOM-CNTRL4 3 0 1 1 10
AOM-CNTRL5 3 0 2 1 15
AOM-CNTRL6 1 0 1 2 5
AOM-CNTRL7 3 0 2 2 15
IL10-CNTRL1 3 0 3 1 35
IL10-CNTRL2 3 0 2 1 35
IL10-CNTRL3 3 0 2 1 30
IL10-CNTRL4 3 0 2 1 25
AOM-CAn: carcinomas of AOM/DSS-colitis. IL10CAn: carcinomas of IL10
2/2-mice.
CNTRLn: premalignant tissue.
DNA-ploidy was assessed according to Auer (please refer to the text). p53 was
assessed semiquantitatively, 0: no expression, 1 1–20% positive mucosa cells, 2:
21–50%, 3.50%
Beta-catenin: 1: membranous, 2: membranous-cytoplasmatic, 3: cytoplasmatic,
4: cytoplasmatic-nulcear, to 5, nuclear.
doi:10.1371/journal.pone.0022114.t001
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Chronic intestinal inflammation in both models as
prerequisite for tumorigenesis
Chronic inflammation at the site of tumorigenesis was character-
ized by a significant increase of the histological inflammation score in
parallel to elevated IFNc levels in the colon culture supernatants of
both models when compared to healthy controls (figure 1b).
IL-102/2 colitis results in chromosomally stable tumors
A total of four IL-102/2 mice developed invasive colorectal
carcinomas devoid of CIN. Figure 2a shows a DNA-histogram of
inflamed mucosa and an example of an invasive carcinoma in IL-
102/2 mice, both depicting a diploid-proliferative pattern. Histo-
grams indicate a proliferating tumor without gross instability of the
genome. In total, all four carcinomas of IL-102/2 mice presented
diploid patterns. Likewise, all non-neoplastic mucosa samples showed
diploid histograms. All non-neoplastic mucosa samples that were
applied for DNA-cytometry and IHC presented with signs of chronic
inflammation (average inflammation score of 2.1), while absence of
neoplasia was ensured histologically (tumor score =0).
AOM induced tumors that arise in mice treated with DSS
show signs of gross CIN
Non-malignant mucosa after administration of AOM and DSS
revealed a diploid pattern in DNA-cytometry (n = 7/7). Chronic
inflammation was present in all non-neoplastic biopsies with an
average inflammation score of 0.5, tumor score = 0.
Figure 1. Murine models of inflammation-driven carcinogenesis. (A) Endoscopic images of inflamed mucosa and tumor of AOM/DSS-colitis
as well as the IL102/2 model. Tumorigenesis was assessed by high resolution endoscopy in vivo. Methylene blue was used to enhance dysplasia
detection as shown exemplarily for AOM/DSS colitis (B) Tumor size as rated by the tumor size score described in the methods section, IFNc -levels,
and inflammation score as assessed in H.E. staining for untreated controls, AOM/DSS-mice, and IL102/2 mice. Bars represent means, whishkers
represent standard error of the mean (SEM). Colonic mucosa samples of 10 healthy untreated C57BL/6J-mice were applied to assess histologic
parameters and IFNc -expression.
doi:10.1371/journal.pone.0022114.g001
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Overt colorectal neoplasms on the basis of AOM/DSS-colitis
presented aneuploidy with a significant amount of cells exceeding
4 c (figure 2b). In total, 13 out of 16 carcinomas arising in
AOM/DSS-colitis showed aneuploidy reflecting CIN. The
frequency of aneuploidy differed significantly between AOM/
DSS-induced tumors and IL-102/2-induced tumors (p = 0.007).
Protein expression of CRC-associated gene products
differs between both tumor types
In all IL-102/2 carcinomas (n = 4), membranous beta-catenin
localization was found, while this was the case for two out of 16
AOM/DSS-induced tumors. In nine out of 16 AOM/DSS-
induced carcinomas, nuclear or nuclear and cytoplasmatic beta-
catenin expression was observed (table 1). The distribution of
beta-catenin expression differed significantly between both groups
(p = 0.020). In four out of seven non-malignant controls of AOM/
DSS-colitis, membranous localization was observed, while the
remaining three mucosa samples were characterized by membra-
nous and cytoplasmatic expression, none showed nuclear expres-
sion. All four non-malignant controls of IL-102/2 colitis presented
membranous expression of beta-catenin.
In IL-102/2 colitis as well as in IL-102/2-induced tumors, very
high levels of p53-protein expression were detected. In contrast,
while p53 expression was still elevated in AOM/DSS-colitis, it was
significantly below that observed in IL-102/2 tumors (p = 0.010,
table 1). In addition, premalignant mucosa of AOM/DSS-colitis
revealed significantly lower p53-expression than AOM/DSS-
induced CRCs (p = 0.015).
Within the group of AOM/DSS-induced tumors, there was
neither a significant correlation between the presence of
aneuploidy and beta-catenin expression (p = 0.580) nor between
aneuploidy and p53 expression (p = 0.730). The growth fraction of
the tumor was generally higher in IL-102/2-induced than in
AOM/DSS-colitis-induced carcinomas (table 1). Thus, high
expression of Ki67 was observed for premalignant mucosa of IL-
102/2 animals, while it was low in premalignant stages of AOM/
DSS-induced colitis (table 1, figure 3).
Discussion
Previously, a significantly higher frequency of aneuploidy
reflecting chromosomal instability in human colitis-associated
carcinomas as compared to the sporadic counterpart has been
Figure 2. DNA-histograms. (A) Representative DNA histograms on logarithmic scale of premalignant and malignant tissue of IL-102/2 mice. Both
histograms depict diploid proliferative patterns. (B) Mice treated with AOM/DSS showed diploid-proliferative patterns in premalignant stages. In the
here presented example of CAC, 23% of all cells measured exceeded the threshold of 4.5 c, representing an aneuploid cell population.
doi:10.1371/journal.pone.0022114.g002
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described [10]. To assess whether canonical mouse models of
colitis-associated carcinogenesis exist that equally exhibit signs of
CIN, we investigated ploidy patterns in murine colitis-associated
neoplasms of two murine models of CAC.
In IL-102/2 mice, neoplasms develop that resemble human
adenocarcinomas, which has been described previously
[26,31,32]. Severity of inflammation can be aggravated and
malignant transformation accelerated by additional administration
of celecoxib [25]. Carcinomas of the IL-102/2 /celecoxib model
did not exhibit signs of genomic instability in our study.
Contrarily, tumors arising in the AOM/DSS-model presented
with gross aneuploidy in the vast majority of cases. Although the
number of specimens investigated differed between both groups
with a considerably smaller number in the IL-102/2-group,
differences in the frequency of aneuploidy reached the level of
significance. The presence of biological differences between CACs
in both models is furthermore suggested by differential expression
of beta-catenin.
In IL-102/2 mice no extrinsic carcinogen is required to induce
tumorigenesis. However, the complete absence of a critical
cytokine for intestinal homeostasis represents an unphysiological
state, even though altered IL-10 expression has previously been
associated with human UC [33,34]. Our data provide evidence
that chronic inflammation due to IL-10 deficiency does not induce
CIN, despite the presence of severe colonic inflammation.
Moreover, further characterization of the tumors indicates that
beta-catenin expression in premalignant stages and in carcinomas
is confined to the cell membrane. This seems to stand in contrast
to human CACs, in which APC mutations are thought to inhibit
beta-catenin degradation and thereby promote nuclear transloca-
tion, although detailed data in humans is missing [18], whereas the
high expression of phosphorylated p53 observed in these tumors is
congruent with results in human UC-associated carcinomas [13].
In AOM/DSS colitis, an extrinsic carcinogen is needed to
induce malignant transformation. Administration of DSS – and
thereby initiation of chronic colitis – accelerates malignancy
development, rendering the model particularly interesting for the
study of colitis-associated carcinogenesis [22,35]. Here, we could
show that a high percentage of CACs that arise after AOM/DSS
treatment exhibit CIN (81.25%). This finding is particularly
remarkable since it has previously been demonstrated that CRCs
induced by administration of AOM alone, which therefore arise
devoid of chronic inflammation, are genetically stable [23]. Thus,
it can be hypothesized that similar to human colitis, murine
Figure 3. Immunohistochemistry for beta-catenin, p53 and Ki67 of murine premalignant tissue and CACs, details of 100x
magnification.
doi:10.1371/journal.pone.0022114.g003
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colonic inflammation induces or significantly contributes to CIN.
AOM/DSS colitis might therefore provide a powerful model to
study the development of inflammation-induced CIN in vivo.
Furthermore, in AOM/DSS induced tumors, cytoplasmatic and/
or nuclear translocation of beta-catenin was observed, indicating
activation of the Wnt-signaling pathway [18,36].
Expression of phosphorylated p53 was increased in AOM/DSS
induced tumors, alongside with an increase in growth fraction as
compared to premalignant stages. No association between the
presence of aneuploidy and expression of p53 or beta-catenin
could be shown, which might be due to insufficient numbers (n = 3
for the diploid group). Larger studies would be necessary to
elucidate differential expression of tumor-associated proteins in
relation to CIN in this murine model.
In neither of both models investigated in this study, macroscopic
distant metastases could be observed. This is in line with previous
findings [26,37], but stands in contrast to CRCs in humans, in
which liver metastases occur in up to 50% of patients during the
course of the disease [38]. In this context, inevitable limitations to
translate biological findings from mice into the human system have
to be appreciated. For CIN in inflammation-associated carcino-
genesis specifically, telomere shortening could be associated with
increased genomic instability [39]. As differences exist between
murine and human telomere biology with mice bearing longer
telomeres and constitutive telomerase activity [40], it might be
questionable to address telomere attrition in the AOM/DSS
model. However, e. g. in murine epithelial cancers, telomere and
telomerase dysfunction have been shown to be pivotal for tumor
development, exemplifying a possible role for telomere biology in
murine carcinogenesis [41]. Furthermore, other mechanisms such
as chromatid cohesion defects have been associated with CIN in
CRC, which involve proteins highly similar in man and mice and
studied in both organisms [42,43].
In summary, IL-10-deficient mice do not represent a suitable
animal model for the study of the CIN pathway of carcinogenesis.
In addition, tumor development in this model does not depend on
beta-catenin translocation.
Contrarily, with presence of aneuploidy and beta-catenin
activation, the model of AOM/DSS-colitis might provide a
valuable tool to gain a more detailed insight into the molecular
architecture of inflammation-associated carcinogenesis and mech-
anistically investigate colitis-associated carcinogenesis with special
regard to CIN.
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